REXAHN PHARMACEUTICALS, INC. (181) | Human Resources (20)
Browse by Subcategory
Recent Contracts
-
Interim President and CEO Consulting Letter Agreement by and between Ocuphire Pharma, Inc. and Richard Rodgers, dated April 20, 2023
(Filed With SEC on May 15, 2023)
-
Non-Employee Director Compensation Policy
(Filed With SEC on May 15, 2023)
-
First Amendment to the Amended and Restated Employment Agreement by and among the Company and Mina Sooch, effective as of March 26, 2023
(Filed With SEC on March 30, 2023)
-
First Amendment to the Amended and Restated Employment Agreement by and among the Company and Bernhard Hoffmann, effective as of March 26, 2023
(Filed With SEC on March 30, 2023)
-
Form of Restricted Stock Unit Grant Notice issued under the Ocuphire Pharma, Inc. 2020 Equity Incentive Plan
(Filed With SEC on March 30, 2023)
-
Form of Stock Option Grant Notice issued under the Ocuphire Pharma, Inc. 2020 Equity Incentive Plan
(Filed With SEC on March 30, 2023)
-
First Amendment to the Employment Agreement by and among the Company and Amy Rabourn, effective as of March 26, 2023
(Filed With SEC on March 30, 2023)
-
First Amendment to the Consulting Agreement dated September 19, 2022, by and between the Company and Jay Pepose
(Filed With SEC on March 30, 2023)
-
Second Amendment to the Consulting Agreement dated December 1, 2022, by and between the Company and Jay Pepose
(Filed With SEC on March 30, 2023)
-
Non-Employee Director Compensation Policy
(Filed With SEC on August 12, 2022)
-
Consulting Agreement between the Registrant and Jay Pepose dated April 8, 2022
(Filed With SEC on May 13, 2022)
-
Employment Agreement dated November 11, 2020, by and between the Company and Amy Rabourn
(Filed With SEC on March 11, 2021)
-
Non-Employee Director Compensation Policy of the Company
(Filed With SEC on November 6, 2020)
-
Employment Agreement, dated as of October 1, 2018, between Ocuphire Pharma, Inc. and Mina Sooch
(Filed With SEC on July 6, 2020)
-
Amended and Restated Employment Agreement by and among Ocuphire Pharma, Inc. and Mina Sooch, to be effective as of the Closing
(Filed With SEC on July 6, 2020)
-
Employment Agreement, dated as of October 1, 2018, between Ocuphire Pharma, Inc. and Bernhard Hoffmann
(Filed With SEC on July 6, 2020)
-
Amended and Restated Employment Agreement by and among Ocuphire Pharma, Inc. and Bernhard Hoffmann, to be effective as of the Closing
(Filed With SEC on July 6, 2020)
-
Ocuphire Pharma, Inc. 2018 Equity Incentive Plan, dated as of April 9, 2019
(Filed With SEC on July 6, 2020)
-
First Amendment to 2018 Equity Incentive Plan, dated as of December 23, 2019
(Filed With SEC on July 6, 2020)
-
Form of Option Agreement issuable under the Ocuphire Pharma, Inc. 2018 Equity Incentive Plan
(Filed With SEC on July 6, 2020)